Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Graft vs Host Disease

ribavirin has been researched along with Graft vs Host Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's2 (20.00)18.2507
2000's5 (50.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, N; Ford, R; Norvell, JP; Parekh, S; Pillai, AA; Spivey, JR; Wedd, J; Young, N1
Avetisyan, G; Ljungman, P; Mattsson, J; Sparrelid, E1
Shanley, RM; Slabý, J; Smith, AR; Ustun, C; Vydra, J; Wagner, JE; Weisdorf, DJ; Young, JA1
Fujimi, A; Hirayama, Y; Iyama, S; Kohda, K; Kuribayasi, K; Matsunaga, T; Murase, K; Niitsu, Y; Sakamaki, S; Sato, T1
Bueso-Ramos, C; Chaves, J; Huen, A; Safdar, A; Vadhan-Raj, S1
Bailey, AS; Carr, TF; Coussons, M; Grainger, JD; Guiver, M; Khalid, T; Mutton, KJ; Sivaprakasam, P; Turner, AJ; Wynn, RF1
Bryan, C; Cushing, H; Hackman, RC; Holt, S; Liles, WC1
Caul, EO; Cornish, JM; Foot, AB; Grier, D; Kelly, C; Kingman, HM; Marks, DI; McCarthy, AJ; Moppett, J; Oakhill, A; Pamphilon, DH; Steward, CG; Taylor, GS1
Chakrabarti, S; Collingham, KE; Fegan, CD; Holder, K; Milligan, DW; Osman, H1
Allegrucci, M; Ballerini, P; Bianchi, R; Borghi, C; Fioretti, MC; Puccetti, P; Romani, L1

Trials

2 trial(s) available for ribavirin and Graft vs Host Disease

ArticleYear
Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:2

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Gastroenterology; Genotype; Graft vs Host Disease; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir; Treatment Outcome; Viral Load

2016
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
    Bone marrow transplantation, 1999, Volume: 24, Issue:12

    Topics: Adolescent; Adult; Child; Child, Preschool; Genotype; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Radiography, Thoracic; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Homologous; Treatment Outcome

1999

Other Studies

8 other study(ies) available for ribavirin and Graft vs Host Disease

ArticleYear
Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Transplantation, 2009, Nov-27, Volume: 88, Issue:10

    Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Antiviral Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Male; Middle Aged; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome

2009
Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:10

    Topics: Adolescent; Adult; Age Factors; Antiviral Agents; Child; Child, Preschool; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Paramyxoviridae Infections; Respiratory Tract Infections; Respirovirus; Retrospective Studies; Ribavirin; Risk Factors; Survival Analysis; Transplantation Conditioning; United States; Unrelated Donors

2012
[Successful treatment with oral ribavirin of adenovirus-associated hemophagocytic syndrome in a stem cell transplantation recipient].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:5

    Topics: Adenoviridae Infections; Administration, Oral; Anemia, Aplastic; Antiviral Agents; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Ribavirin; Treatment Outcome

2005
Aerosolized ribavirin-induced reversible hepatotoxicity in a hematopoietic stem cell transplant recipient with Hodgkin lymphoma.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Apr-15, Volume: 42, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Aerosols; Antiviral Agents; Bilirubin; Bone Marrow Transplantation; Female; Graft vs Host Disease; Hodgkin Disease; Humans; Liver; Liver Function Tests; Ribavirin; Stem Cell Transplantation

2006
Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2

    Topics: Adenovirus Infections, Human; Adolescent; Antiviral Agents; Blood; Bronchoalveolar Lavage Fluid; Child; Cidofovir; Cytosine; Feces; Female; Fluorescent Antibody Technique; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Infant; Male; Microscopy, Electron, Transmission; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin

2007
Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin.
    Bone marrow transplantation, 1993, Volume: 12, Issue:4

    Topics: Adenoviridae Infections; Adult; Bone Marrow Transplantation; Cystitis; Graft vs Host Disease; Hemorrhage; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Male; Nephritis; Ribavirin; Salvage Therapy

1993
Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Administration, Oral; Adult; Anemia; Anemia, Aplastic; Antiviral Agents; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Nausea; Parainfluenza Virus 3, Human; Pilot Projects; Pneumonia, Viral; Population Surveillance; Prospective Studies; Respiratory Syncytial Virus Infections; Respirovirus Infections; Ribavirin; Transplantation Conditioning; Treatment Outcome

2001
Immunopharmacological studies of ribavirin, a broad-spectrum antiviral agent.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Animals; Cytotoxicity, Immunologic; Female; Graft vs Host Disease; Hypersensitivity, Delayed; Immunity, Innate; In Vitro Techniques; Killer Cells, Natural; Lymphocyte Activation; Lymphocyte Transfusion; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Pseudomonas Infections; Ribavirin; Ribonucleosides; Transplantation, Homologous

1987